 "Laxmi Dental's Rs 698 cr IPO to open on Jan 13 at price band of Rs 407-428")
OrbiMed-backed Laxmi Dental on Wednesday said it has fixed the price band at Rs 407-428 per share for Rs 698 crore initial public offer which will hit the markets for public subscription on January 13.
The company has decreased the size of its fresh issuance from Rs 150 crore to Rs 138 crore and expanded OFS (offer for sale) size from 1.28 crore equity shares to nearly 1.31 crore shares.
The initial public offerings (IPO) will conclude on January 15, while bidding for anchor investors is to open for a day January 10, the company said in a statement.
At the upper end of the price band, the company is expecting to fetch about Rs 698 crore from the public issue.
The IPO is a combination of fresh issue of equity shares up to Rs 138 crore and an OFS of up to 1.31 crore equity shares by promoters -- Rajesh Vrajlal Khakhar and Sameer Kamlesh Merchant, and other shareholders, according to the Red Herring Prospectus (RHP) filed on January 7.
Under the OFS, investor OrbiMed Asia II Mauritius Ltd will also offload shares of the leading B2C dental aligner company Laxmi Dental.
Also Read
The promoters and promoter group owned a 46.56 per cent stake in Laxmi Dental, while public shareholders hold a 53.44 per cent holding.
As per the RHP, the net proceeds from the fresh issue will be utilised for repayment of debt, funding of capital expenditure requirements, investment in its subsidiary Bizdent Devices Pvt Ltd and general corporate purposes.
Laxmi Dental, an end-to-end integrated dental products company, has a comprehensive portfolio that includes custom-made crowns and bridges, branded dental products such as aligner solutions and paediatric dental products.
Nuvama Wealth Management, Motilal Oswal Investment Advisors, SBI Capital Markets are the book running lead managers, and MUFG Intime India Pvt Ltd (formerly Link Intime India Pvt Ltd) as the registrar for the IPO.
The shares of the company will be listed on the BSE and NSE.